TY  - JOUR
AU  - Bellasi, Antonio
AU  - Raggi, Paolo
AU  - Bover, Jordi
AU  - Bushinsky, David A
AU  - Chertow, Glenn M
AU  - Ketteler, Markus
AU  - Rodriguez, Mariano
AU  - Sinha, Smeeta
AU  - Salcedo, Carolina
AU  - Garg, Rekha
AU  - Gold, Alex
AU  - Perelló, Joan
PY  - 2019
DO  - 10.1093/ckj/sfz144
SN  - 2048-8505
UR  - https://hdl.handle.net/10668/25827
T2  - Clinical kidney journal
AB  - The objective of CaLIPSO, a Phase 2b, randomized, double-blind, placebo-controlled clinical trial, is to test the hypothesis that myo-inositol hexaphosphate (SNF472) attenuates the progression of cardiovascular calcification in patients receiving...
LA  - en
KW  - SNF472
KW  - chronic kidney disease
KW  - coronary artery calcification
KW  - randomized clinical trial
KW  - vascular calcification
TI  - Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcification.
TY  - research article
VL  - 14
ER  -